Anúncio
Anúncio
SNDX
Syndax Pharmaceuticals, Inc.
21.00
USDPatrocinado
-0.38
-1.78%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
21.04
+0.04
+0.17%
Relatórios de Lucros SNDX
Rácio de surpresa positiva
SNDX separação 29 de 39 últimas estimativas.
74%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$65.38M
/-$0.60
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+42.54%
/-14.29%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+751.34%
/-45.45%
Syndax Pharmaceuticals, Inc. earnings per share and revenue
On 03 de nov. de 2025, SNDX reported earnings of -0.70 USD per share (EPS) for Q3 25, beating the estimate of -0.73 USD, resulting in a 4.24% surprise. Revenue reached 45.87 milhão, compared to an expected 48.94 milhão, with a -6.26% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of -0.60 USD, with revenue projected to reach 65.38 milhão USD, implying an diminuir of -14.29% EPS, and aumentar of 42.54% in Revenue from the last quarter.
FAQ
What were Syndax Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Syndax Pharmaceuticals, Inc. reported EPS of -$0.70, beating estimates by 4.24%, and revenue of $45.87M, -6.26% below expectations.
How did the market react to Syndax Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 11.56%, changed from $13.76 before the earnings release to $15.35 the day after.
When is Syndax Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Syndax Pharmaceuticals, Inc.'s next earnings report?
Based on 16
analistas, Syndax Pharmaceuticals, Inc. is expected to report EPS of -$0.60 and revenue of $65.38M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio